1-16 of 16
Authors: Raelene Endersby
Sort by
Journal Article
MDB-65. RESULTS FROM THE SJ-ELIOT PHASE 1 CLINICAL TRIAL EVALUATING PREXASERTIB (LY2606368) IN COMBINATION WITH CYCLOPHOSPHAMIDE OR GEMCITABINE FOR CHILDREN AND ADOLESCENTS WITH REFRACTORY OR RECURRENT MEDULLOBLASTOMA Open Access
Nicholas G Gottardo and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.514
Published: 18 June 2024
Journal Article
MODL-16. CRANIOSPINAL RADIOTHERAPY IN COMBINATION WITH DNA-DAMAGE RESPONSE INHIBITORS IN PATIENT-DERIVED ORTHOTOPIC XENOGRAFT MODELS OF MEDULLOBLASTOMA Open Access
Hilary Hii and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.760
Published: 18 June 2024
Journal Article
EXTH-36. COMBINING ONC201 AND PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA (DMG); THE PRECLINICAL RESULTS UNDERPINNING THE INTERNATIONAL PHASE II CLINICAL TRIAL (NCT05009992) Free
Evangeline Jackson and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v232, https://doi.org/10.1093/neuonc/noad179.0889
Published: 10 November 2023
Journal Article
BIOL-12. ENHANCING IMMUNE-MEDIATED TUMOR CONTROL IN MURINE MODELS OF GROUP 3 MEDULLOBLASTOMA Open Access
Zahra Abbas and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i8, https://doi.org/10.1093/neuonc/noad073.031
Published: 12 June 2023
Journal Article
RONC-07. Fractionated radiotherapy is required to accurately mimic neurostructural late effects in preclinical models Open Access
Jacqueline Whitehouse and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i177–i178, https://doi.org/10.1093/neuonc/noac079.661
Published: 03 June 2022
Journal Article
MODL-18. Enhancing anti-CD47 mAb efficacy with radiotherapy for Group 3 paediatric medulloblastoma in preclinical models Open Access
Zahra Abbas and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i172–i173, https://doi.org/10.1093/neuonc/noac079.641
Published: 03 June 2022
Journal Article
MODL-19. Exploiting DNA damage response inhibitors to enhance radiation efficacy in medulloblastoma models Open Access
Hetal Dholaria and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i173, https://doi.org/10.1093/neuonc/noac079.642
Published: 03 June 2022
Journal Article
Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma Free
Taciani de Almeida Magalhães and others
Neuro-Oncology, Volume 25, Issue 1, January 2023, Pages 185–198, https://doi.org/10.1093/neuonc/noac147
Published: 31 May 2022
Journal Article
EMBR-03. PINEOBLASTOMA: A POOLED OUTCOME STUDY OF NORTH AMERICAN AND AUSTRALIAN THERAPEUTIC DATA Open Access
Jordan Hansford and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i6, https://doi.org/10.1093/neuonc/noab090.021
Published: 01 June 2021
Journal Article
DIPG-50. A NOVEL ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODEL OF RADIATION-INDUCED GLIOMA Open Access
Jacqueline Whitehouse and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii296, https://doi.org/10.1093/neuonc/noaa222.095
Published: 04 December 2020
Journal Article
RONC-02. MEASURING THE EFFECT OF CLINICALLY-RELEVANT RADIOTHERAPY PROTOCOLS ON THE JUVENILE MOUSE BRAIN Open Access
Jessica Buck and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii456, https://doi.org/10.1093/neuonc/noaa222.775
Published: 04 December 2020
Journal Article
Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma Free
Sameer A Greenall and others
Neuro-Oncology, Volume 21, Issue 8, August 2019, Pages 1016–1027, https://doi.org/10.1093/neuonc/noz073
Published: 19 April 2019
Journal Article
RONC-14. REPLICATING CLINICAL RADIATION THERAPY PROTOCOLS IN PRECLINICAL BRAIN TUMOUR MODELS Free
Raelene Endersby and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i177, https://doi.org/10.1093/neuonc/noy059.676
Published: 22 June 2018
Journal Article
MBRS-35. COMBINING Chk1/2 INHIBITION WITH RADIATION ENHANCES IN VITRO AND IN VIVO CYTOTOXICITY IN MEDULLOBLASTOMA Free
Raelene Endersby and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i135–i136, https://doi.org/10.1093/neuonc/noy059.480
Published: 22 June 2018
Journal Article
PNR-31INHIBITING CELL CYCLE CHECKPOINTS IMPROVES THE EFFICACY OF CHEMOTHERAPY IN PINEOBLASTOMA Free
Raelene Endersby and others
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii12, https://doi.org/10.1093/neuonc/now067.26
Published: 30 May 2016
Journal Article
MB-75EXPLOITING THE CELL CYCLE TO IMPROVE TREATMENT EFFICACY IN MEDULLOBLASTOMA Free
Raelene Endersby and others
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii114, https://doi.org/10.1093/neuonc/now076.71
Published: 30 May 2016
Advertisement
Advertisement